April 28, 2021
A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately ...
Read more >
May 13, 2021
Myocardial Solutions (“MSI”) technologies MyoStrain® (fSENC) was featured in a newly published article exploring the effectiveness of cardiovascular magnetic resonance (CMR) and segmental strain to detect ischemia in patients suspected of obstructive coronary artery disease (CAD)...
Read more >
April 20, 2021
A new article published in the Journal of Cardiovascular Magnetic Resonance utilized MyoStrain (fast-SENC) to accurately risk-stratify asymptomatic cardiac patients across multiple disease states. The article demonstrated MyoStrain’s clinical utility as a critical risk stratification tool to ...
Read more >
February 21, 2021
Myocardial Solutions, Inc. (“MSI”) attended the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th Annual Scientific Sessions, held virtually February 18-20, 2021. This year, SCMR main topics focused on new and traditional use cases of CMR, as well as exploring the use of CMR ...
Read more >
February 17, 2021
Myocardial Solutions,Inc. (“MSI”) will attend the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th annual scientific sessions virtually from February 18-21, 2021. The event focuses on highlighting breakthrough developments in new cardiovascular magnetic resonance (CMR) techniques ...
Read more >
February 11, 2021
A new article published in the European Society of Cardiology (ESC) Heart Failure Journal demonstrated MyoStrain’s ability to accurately detect and delineate patterns of myocardial dysfunction between heart failure (HF) types and severity...
Read more >
January 25, 2021
A new pivotal research paper published in the Journal of American College of Cardiology (JACC) Cardiovascular Imaging presents several key validations for the clinical use of MyoStrain® in determining the risk of heart failure across multiple cardiac disease states.
Read more >
December 8, 2020
Philips Healthcare presented MyoStrain® at RSNA 2020 and discussed how MyoStrain's MRI-based cardiac diagnostic solutions may help transform cardiovascular care and enable physicians to quantify subtle changes in intra-myocardial heart function.
Read more >
October 8, 2020
Myocardial Solutions (MSI) featured MyoStrain® in a satellite symposium at the first ever International Cardio-Oncology Summit 2020, a joint CardioTox and Global Cardio-Oncology Society (GCOS) initiative attracting oncologists, cardiologists, radiologists and pharmacists from around the world to ...
Read more >
September 24, 2020
MyoStrain® was included in a new article published in the Journal of Cardiovascular Magnetic Resonance (JCMR) by the Society of Cardiovascular Magnetic Resonance (SCMR). The paper provides specific and detailed recommendations on the use of cardiovascular magnetic resonance (CMR) protocols for...
Read more >
